Arjo Logo

Arjo

ISIN: SE0010468116 | Ticker: ARJO | LEI: 549300OWGJPYKC6JF790
Sector: Health CareSub-Industry: Health Care Distributors
Country: Sweden

About Arjo

Company Description

At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism.

With over 6000 people worldwide and 60 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges.

Year founded

1957

Served area

Worldwide

Headcount

6,000

Headquarters

Hans Michelsensgatan 10, 20120 Malmö – Sweden

Financial statements

Download as Excel
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 13,858,000,000.00 14,612,000,000.00 16,167,000,000.00
Noncurrent Assets N/A 9,728,000,000.00 10,437,000,000.00 11,137,000,000.00
Property Plant And Equipment N/A 1,282,000,000.00 1,454,000,000.00 1,802,000,000.00
Investment Accounted For Using Equity Method N/A 120,000,000.00 123,000,000.00 132,000,000.00
Other Noncurrent Financial Assets N/A 134,000,000.00 117,000,000.00 119,000,000.00
Noncurrent Recognised Assets Defined Benefit Plan N/A 33,000,000.00 238,000,000.00 205,000,000.00
Noncurrent Finance Lease Receivables N/A 21,000,000.00 51,000,000.00 38,000,000.00
Current Assets N/A 4,130,000,000.00 4,175,000,000.00 5,030,000,000.00
Inventories N/A 1,039,000,000.00 1,369,000,000.00 1,674,000,000.00
Current Trade Receivables N/A 1,500,000,000.00 1,542,000,000.00 1,708,000,000.00
Other Current Receivables N/A 282,000,000.00 209,000,000.00 283,000,000.00
Current Tax Assets Current N/A 71,000,000.00 18,000,000.00 87,000,000.00
Other Current Financial Assets N/A 14,000,000.00 2,000,000.00 0.00
Cash and cash equivalents 662,000,000.00 972,000,000.00 757,000,000.00 949,000,000.00
Current Derivative Financial Assets N/A 19,000,000.00 26,000,000.00 45,000,000.00
Current Finance Lease Receivables N/A 13,000,000.00 24,000,000.00 21,000,000.00
Equity And Liabilities N/A 13,858,000,000.00 14,612,000,000.00 16,167,000,000.00
Issued Capital N/A 91,000,000.00 91,000,000.00 91,000,000.00
Retained Earnings N/A 5,367,000,000.00 6,028,000,000.00 6,138,000,000.00
Other Reserves N/A 172,000,000.00 766,000,000.00 1,395,000,000.00
Equity Attributable To Owners Of Parent N/A 5,630,000,000.00 6,885,000,000.00 7,624,000,000.00
Noncurrent Liabilities N/A 3,014,000,000.00 1,238,000,000.00 3,922,000,000.00
Other Longterm Provisions N/A 64,000,000.00 71,000,000.00 69,000,000.00
Noncurrent Recognised Liabilities Defined Benefit Plan N/A 37,000,000.00 32,000,000.00 29,000,000.00
Current Liabilities N/A 5,214,000,000.00 6,490,000,000.00 4,621,000,000.00
Other Shortterm Provisions N/A 75,000,000.00 57,000,000.00 67,000,000.00
Trade And Other Current Payables To Trade Suppliers N/A 504,000,000.00 614,000,000.00 587,000,000.00
Current Accruals And Current Deferred Income Including Current Contract Liabilities N/A N/A 1,021,000,000.00 942,000,000.00
Current Tax Liabilities Current N/A 22,000,000.00 61,000,000.00 106,000,000.00
Other Current Financial Liabilities N/A 3,051,000,000.00 4,177,000,000.00 2,322,000,000.00
Current Derivative Financial Liabilities N/A 32,000,000.00 16,000,000.00 26,000,000.00
Other Current Liabilities N/A 293,000,000.00 216,000,000.00 212,000,000.00
Line item in (sek) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 9,078,000,000.00 9,070,000,000.00 9,979,000,000.00
Other Income 7,000,000.00 17,000,000.00 31,000,000.00
Profit Loss From Operating Activities 866,000,000.00 1,077,000,000.00 691,000,000.00
Finance Income 5,000,000.00 11,000,000.00 42,000,000.00
Finance Costs 169,000,000.00 98,000,000.00 135,000,000.00
Other Income Expense From Subsidiaries Jointly Controlled Entities And Associates 0.00 -9,000,000.00 -10,000,000.00
Profit Loss Before Tax 702,000,000.00 989,000,000.00 597,000,000.00
Income Tax Expense Continuing Operations 175,000,000.00 247,000,000.00 149,000,000.00
Profit (loss) 526,000,000.00 742,000,000.00 447,000,000.00
Profit Loss Attributable To Owners Of Parent 526,000,000.00 742,000,000.00 447,000,000.00
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A 526,000,000.00 742,000,000.00 447,000,000.00
Adjustments For Finance Costs N/A -28,000,000.00 -4,000,000.00 6,000,000.00
Adjustments For Decrease Increase In Inventories N/A -30,000,000.00 -232,000,000.00 -165,000,000.00
Adjustments For Depreciation And Amortisation Expense N/A N/A 956,000,000.00 1,077,000,000.00
Other Adjustments For Noncash Items N/A 56,000,000.00 -2,000,000.00 -7,000,000.00
Interest Paid Classified As Operating Activities N/A 101,000,000.00 89,000,000.00 116,000,000.00
Interest Received Classified As Operating Activities N/A 5,000,000.00 4,000,000.00 16,000,000.00
Income Taxes Paid Refund Classified As Operating Activities N/A 132,000,000.00 132,000,000.00 233,000,000.00
Cash Flows From Used In Operating Activities N/A 2,267,000,000.00 1,734,000,000.00 915,000,000.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 49,000,000.00 19,000,000.00 0.00
Cash Flows From Used In Investing Activities N/A -972,000,000.00 -695,000,000.00 -902,000,000.00
Proceeds From Borrowings Classified As Financing Activities N/A 8,574,000,000.00 9,942,000,000.00 24,328,000,000.00
Repayments Of Borrowings Classified As Financing Activities N/A 8,791,000,000.00 10,808,000,000.00 23,747,000,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 327,000,000.00 330,000,000.00 377,000,000.00
Cash Flows From Used In Financing Activities N/A -963,000,000.00 -1,277,000,000.00 136,000,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 332,000,000.00 -237,000,000.00 150,000,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -22,000,000.00 22,000,000.00 42,000,000.00
Cash and cash equivalents 662,000,000.00 972,000,000.00 757,000,000.00 949,000,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
SWE
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
20.10.23 Johan Malmquist Other Buy SEK 1,785,430.00
04.09.23 Karl Joacim Claesson Lindoff Other Buy SEK 1,068,500.00
31.08.23 Dan Frohm Other Buy SEK 340,490.00
31.08.23 Dan Frohm Other Buy SEK 339,178.60
10.08.23 Johan Malmquist Other Buy SEK 2,136,500.00
27.04.23 Jonas Cederhage Other Buy SEK 30,940.00
25.04.23 Jonas Cederhage Other Sell SEK 30,632.00
28.02.23 Marion Gullstrand Other Buy SEK 647,110.00
28.02.23 Maria Nilsson Other Buy SEK 84,323.00
28.02.23 Ingrid Carlsson Other Buy SEK 78,460.00

Short Interest


Current short interest

Position Holder Short Interest in Percent Date
ALCUR FONDER AB 0.53% 14.03.24
Total 0.53%

Capital markets information

ISIN

SE0010468116

LEI

549300OWGJPYKC6JF790

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Providers & Services

Sub-Industry

Health Care Distributors

Listed Stock Exchange

Nasdaq Stockholm

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.